tradmap

MNPR Earnings Monopar Therapeutics

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$4 -$2 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $1 $0 2019 2020 2021 2022 2023 2024 2025 2025 2025 2025
Revenue
Net income (annual)
-$16M -$8M $0 2019 2020 2021 2022 2023 2024 2025 2025 2025 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $1 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$11M -$5M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–17 of 17
Q2 20262026-06-30-1.082026-08-1210-Q
Q1 20262026-03-31-0.462026-05-1410-Q
FY 20252025-12-31-1.852026-03-2710-K
Q3 20252025-09-30-1.212025-11-1310-Q
Q2 20262025-06-30-0.732026-08-1210-Q
Q1 20262025-03-31-0.382026-05-1410-Q
FY 20252024-12-31-4.112026-03-2710-K
Q3 20252024-09-30-1.362025-11-1310-Q
Q2 20252024-06-30-1.002025-08-1210-Q
Q1 20252024-03-31-0.512025-05-1310-Q
FY 20242023-12-31-3.042025-03-3110-K
Q3 20242023-09-30-2.432024-11-0810-Q
Q2 20242023-06-30-0.352024-08-0910-Q
Q1 20242023-03-31-0.192024-05-0910-Q
FY 20232022-12-31-0.832024-03-2810-K
Q3 20232022-09-30-0.602023-11-0910-Q
Q2 20232022-06-30-0.412023-08-1010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.